Biogen Idec Moving to Weston?

Massachusetts biotech giant Biogen Idec (NASDAQ: BIIB) is considering a move from Cambridge to Weston, acording to a report in the Boston Globe. Citing Cambridge’s high real estate costs as motivation for the possible change, Biogen CEO Jim Mullen told Globe reporter Todd Wallack that a yet-to-be-built 350,000 square foot building on Boston Post Road “looks like it is the best fit for what we are doing,” though other sites are  under consideration. The Boston Business Journal first reported that Biogen was looking for a new site for its headquarters back in August.

Rebecca is Xconomy's co-founder. Follow @

Trending on Xconomy